Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
08/2010
08/26/2010US20100216699 Semi-synthetic glycopeptides having antibacterial activity
08/26/2010US20100215729 Oligonucleotide analogues incorporating 5-aza-cytosine therein
08/19/2010US20100210509 Long acting hyaluronic acid - peptide conjugate
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/18/2010EP1390521B1 Glycopeptide antibiotics
08/12/2010WO2010089341A1 Novel vancomycin-aminoquinoline hybrid molecules their preparation and their application in therapeutics
08/12/2010US20100203611 Novel nuclear translocation peptide
08/12/2010US20100203076 Complexes of rna and cationic peptides for transfection and for immunostimulation
08/05/2010US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics
08/05/2010US20100197567 Conus polypeptides
08/04/2010CN101796064A Method for producing peptide
08/03/2010CA2468295C Glycoprotein remodeling using endoglycanases
07/2010
07/29/2010US20100190959 Vancomycin b hydrochloride crystalline form 1
07/29/2010US20100190958 Pure vancomycin hydrochloride
07/29/2010US20100190691 Delivery of nucleic acids using cell-penetrating peptides
07/29/2010US20100190660 Methods, Compositions And Libraries Pertaining To PNA Dimer And PNA Oligomer Synthesis
07/29/2010DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses
07/22/2010US20100184948 Molecules for targeting compounds to various selected organs or tissues
07/22/2010US20100184947 Molecules for targeting compounds to various selected organs, tissues or tumor cells
07/22/2010US20100183635 Glycosylated specificity exchangers
07/22/2010US20100183634 Multifunctional nucleic acid nano-structures
07/21/2010EP2208732A1 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use
07/13/2010US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease
07/13/2010CA2347713C Contulakin-g, analogs thereof and uses therefor
07/08/2010US20100172864 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
07/06/2010US7750117 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide
07/01/2010US20100167290 Molecule attachment to nanoparticles
07/01/2010US20100166842 Amphiphilic substances and functionalized lipid vesicles including the same
07/01/2010US20100166770 Antagonists of bacterial sequences
06/2010
06/24/2010US20100160211 Glycopeptide phosphonate derivatives
06/24/2010US20100160210 Guanidinium delivery carriers
06/22/2010CA2242878C Induction of immune response against desired determinants
06/17/2010WO2010068817A1 Glycan-specific analytical tools
06/17/2010US20100151514 substitute substance for human mucin and is useful in fields such as pharmaceutical, agricultural, and food fields; easily in large amounts from jellyfishes and is therefore superior as economical and environmental preservation techniques; accurate determination of the molecular weights
06/17/2010US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker
06/17/2010CA2749588A1 Glycan-specific analytical tools
06/15/2010US7737252 Peptide-based compounds
06/10/2010WO2010065174A1 Novel semi-synthetic glycopeptides as antibacterial agents
06/10/2010US20100144623 C-Terminal Domain Truncation of mGluR1a By Calpain and Uses Thereof
06/10/2010CA2745446A1 Novel semi-synthetic glycopeptides as antibacterial agents
06/09/2010CN1829742B Aminated complex-type sugar chain derivatives and process for the production thereof
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/02/2010CN1946743B Hyaluronic acid/methotrexate compound
06/01/2010US7728127 Cross-linked glycopeptide-cephalosporin antibiotics
06/01/2010US7728104 Process for preparing glycopeptide phosphonate derivatives
06/01/2010US7727956 Deoxonadepsipeptides
05/2010
05/27/2010US20100130591 Multiple exon skipping compositions for dmd
05/27/2010US20100130406 Glycated milk and uses thereof
05/27/2010US20100129889 Affinity separation methods and systems
05/26/2010EP1448602B1 Modified anti-tnf alpha antibody
05/25/2010US7723470 Antibiotic of given structure; vancomycin derivatives; enhanced activity, selectivity and reduced mammalian toxicity
05/19/2010CN101709079A Synthesis method of romurtide
05/13/2010US20100121028 Hydrolysable Polymeric FMOC- Linker
05/13/2010US20100120031 Synthesis of trans-tert-butyl-2-aminocyclopentylcarbamate
05/13/2010US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus
05/12/2010EP2184290A1 Method for producing peptide
05/12/2010CN1738643B Composition and method for preventing or treating a virus infection
05/12/2010CN101024661B Three single-component separation methods for Ramoplanin
05/11/2010US7713931 Cross-linked glycopeptide-cephalosporin antibiotics
05/06/2010WO2010049611A1 Polysaccharide- and polypeptide-based block copolymers, vesicles constituted of these copolymers and use thereof
05/06/2010US20100113333 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
05/06/2010US20100113332 Method of treating an inflammatory disease by double stranded ribonucleic acid
05/06/2010CA2741246A1 Polysaccharide- and polypeptide-based block copolymers, vesicles constituted of these copolymers and use thereof
04/2010
04/29/2010WO2009115782A3 Compounds derived from muramyldipeptide
04/29/2010US20100105607 Novel semi-synthetic glycopeptides as antibacterial agents
04/29/2010US20100105028 Probe for detecting nucleic acids
04/20/2010US7700550 Telavancin or its hydrochloride salt for infection, including MRSA infections; reduced tissue accumulation and/or nephrotoxicity
04/15/2010WO2010006343A3 Glycopeptide constructs and uses thereof
04/15/2010US20100093974 Linkers and Co-Coupling Agents for Optimization of Oligonucleotide Synthesis and Purification on Solid Supports
04/15/2010US20100093609 Prodrugs of triciribine and triciribine phosphate
04/15/2010US20100092957 Compositions and methods for nucleotide sequencing
04/14/2010EP2173759A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses
04/13/2010US7696326 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
04/13/2010US7696164 Substantially pure glycopeptide antibiotics AC-98-1 ; AC-98-2; AC-98-3; AC-98-4 and AC-98-5
04/01/2010WO2009037592A3 Triazole-based aminoglycoside-peptide conjugates and methods of use
04/01/2010US20100081609 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
04/01/2010US20100081187 Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same
03/2010
03/31/2010EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/23/2010CA2290724C Glycopeptide hexapeptides
03/10/2010EP2161276A2 Methods, compositions and libraries pertaining PNA dimer and PNA oligomer systhesis
03/04/2010US20100056612 Molecular entities for binding, stabilization and cellular delivery of charged molecules
03/04/2010US20100056475 Cyclodextrin conjugates
02/2010
02/25/2010US20100048867 Device and process for purifying nucleic acids
02/25/2010US20100048456 Glycopegylation methods and proteins/peptides produced by the methods
02/18/2010US20100041773 Disruptors of early/recycling endosomes
02/18/2010US20100041588 Derivatives of apf and methods of use
02/18/2010US20100041584 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery
02/18/2010US20100041025 Compositons, methods and kits for real-time nucleic acid analysis in live cells
02/18/2010US20100040714 Asthma/Allergy Therapy that Targets T-lymphoctyes and/or Eosinophils
02/11/2010US20100035799 Method for the synthesis of anthracycline-peptide conjugates
02/09/2010US7658929 Derived from pathogenic microorganisms, useful for vaccination and diagnosis; tuberculosis; detection of CD4+ T lymphocytes recognizing at least one glycopeptide obtained from pathogenic microorganism
02/09/2010CA2350417C Dna-protein fusions and uses thereof
02/04/2010US20100029494 Macromolecular Nucleotide Compounds And Methods For Using The Same
02/02/2010US7655621 Cross-linked glycopeptide-cephalosporin antibiotics
02/02/2010CA2407994C Reductive alkylation process
01/2010
01/21/2010US20100016546 Therapeutic Peptide-Polysaccharide Biomaterials
01/21/2010US20100016254 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
01/21/2010US20100016215 Compound and method for treating myotonic dystrophy
01/20/2010CN101628931A Antitumor antibiotics, pharmaceutically acceptable salts thereof, preparation method thereof and use thereof
01/19/2010US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 34